Form 4: Jaguar Health Executive Jonathan S. Wolin Acquires Shares and Stock Options

Jonathan S. Wolin, Chief of Staff, Chief Compliance Officer, and General Counsel of Jaguar Health, Inc., reports acquisition of common stock and stock options.

Summary

• On October 8, 2024, Jonathan S. Wolin acquired 4,922 shares of common stock and 39,376 stock options in Jaguar Health, Inc.
• The stock options have an exercise price of $1.29 and expire on October 8, 2034.
• The options vest ratably on a monthly basis over 36 months from the grant date, contingent upon continued employment.
• Wolin also received 4,922 restricted stock units, each representing a contingent right to receive one share of Jaguar Health's common stock.
• These restricted stock units vest in three equal annual installments beginning on October 8, 2025.
• Following the reported transactions, Wolin directly owns 4,955 shares of common stock and 39,376 stock options.
• The grants were made pursuant to the issuer's 2014 Stock Incentive Plan and approved by the board of directors on October 8, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it is a standard regulatory filing reporting insider transactions. The acquisition of shares and options could be interpreted as a positive sign, but it's not definitively bullish.

Positives

• The acquisition of shares and stock options by a key executive could be seen as a positive sign of confidence in the company's future.

Industry Context

Form 4 filings are standard practice and provide transparency into insider transactions, allowing investors to track the actions of company executives and directors.

Stakeholder Impact

• The reported transactions may influence investor sentiment regarding Jaguar Health, Inc.

Key Dates

Keywords

Jaguar Health, stock options, common stock, Form 4, Jonathan S. Wolin, acquisition, restricted stock units, insider trading